Abbott (NYSE: ABT) announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with ...

Abbott will soon enter the competitive U.S. pulsed field ablation (PFA) market, having just received FDA approval for its ...

Francis Medical designed its Vanquish system with needle guidance and hands-free stabilization for vapor ablation of the ...

After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...

Francis Medical is heating up with a 510 (k) clearance from the FDA for its water vapor ablation therapy aimed at cancers of ...

Medtronic tops the list of the largest cardio device companies, with cardiovascular technology proving a major growth driver.

Thermedical has treated the first patient in a pivotal clinical trial of its saline-enhanced radiofrequency (SERF) ablation ...

MIT-alumni-founded Thermedical advances novel deep-tissue ablation technology to address critical unmet needs in severe ventricular tachycardia ...

Obstructive sleep apnea is associated with increased atrial fibrillation recurrence after ablation in patients with paroxysmal atrial fibrillation.

Radiofrequency ablation can be an effective treatment for neck and back pain, as well as for certain types of growths, like tumors. Although radiofrequency ablation is minimally invasive, it’s normal ...